UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
STAB holding history
Statera Biopharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
STAB overviewAll 13F holders of STABFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −2,011−100.0% | Sold out | Holders |
| Q4 2022 | 2,011 | $161 | <0.1% | −95,888−97.9% | Reduced | Holders |
| Q3 2022 | 97,899 | $13.0K | <0.1% | +89,346+1,044.6% | Added | Holders |
| Q2 2022 | 8,553 | $2.00K | <0.1% | −110,119−92.8% | Reduced | Holders |
| Q1 2022 | 118,672 | $37.0K | <0.1% | +118,672 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −19,470−100.0% | Sold out | Holders |
| Q3 2021 | 19,470 | $45.0K | <0.1% | +19,470 | New | Holders |